KMS Medisurgi Ltd.

125.00 ▼0%

05 April 2024, 04:01:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Industry Icon Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.kmsgroup.in
Market Cap 41.25 Cr.
Enterprise Value(EV) 41.30 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.74 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 72.00 Trailing Twelve Months Ending 2023-03
Industry PE 57.49 Trailing Twelve Months Ending 2023-03
Book Value / Share 21.89 Trailing Twelve Months Ending 2023-03
Price to Book Value 5.71 Calculated using Price: 125.00
Dividend Yield 0.04 Period Ending 2023-03
No. of Shares Subscribed 0.33 Cr. 3,300,000 Shares
FaceValue 10
About KMS Medisurgi Ltd.
They manufacture and undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. They are engaged into the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy equipments, Blood Banking Equipments and other such Surgical Equipments in India. They also undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, taffeta silk fabrics with adhesive. They offer a gamut of products, which includes Absorbable Gelatin Surgical Sponge, Surgipore Tape, Surgipore Tape (Silk), Cushions for ESWL-VI Shock Wave Hand, Dressing Post-Op Medicated, Dresiing Silicon Gel, Micrporus Surgical Foam Tape, Fleece Fabric, and Double Side Adhesive tapes.

KMS Medisurgi Ltd. Delivery

Delivered Qty
Traded Qty

KMS Medisurgi Ltd. Performance

1 Day
1 Week
1 Month
+2.53%
3 Month
+2.53%
6 Month
+37.36%
1 Year
+49.63%
2 Year
+265.50%
5 Year
+313.91%
10 Year

KMS Medisurgi Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.82 6.13 6.26 1.98 1.99 1.78 1.92 3.28 8.25
Return on Capital Employed (%) 7.69 11.39 10.63 5.2 3.86 3.42 3.62 4.28 8.65
Return on Assets (%) 0.44 1.79 2.57 1.02 1.19 1.14 1.33 2.25 5.89

KMS Medisurgi Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 3 4 6 6 6 6 7 7 8
Non Curr. Liab. 2 1 1 1 1 1 1 1 1 0
Curr. Liab. 4 4 4 3 3 2 2 2 2 3
Minority Int.
Equity & Liab. 7 8 9 10 11 9 9 10 10 11
Non Curr. Assets 2 2 3 2 2 2 2 2 2 2
Curr. Assets 5 6 6 8 8 7 8 8 8 9
Misc. Exp. not W/O
Total Assets 7 8 9 10 11 9 9 10 10 11

KMS Medisurgi Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 8 9 8 8 7 10 10 8 10 11
Other Income 0 0 0 0 0 0 0 0 0
Total Income 8 9 8 8 8 10 10 8 10 11
Total Expenditure -7 -8 -8 -7 -7 -10 -10 -7 -10 -10
PBIDT 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 1
Adjusted EPS 0 0 1 1 0 0 0 0 1 2

KMS Medisurgi Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 1 -2 1 -1 1 0 0
Cash Fr. Inv. -2 0 0 -1 0 0 0 0 0 -1
Cash Fr. Finan. 2 -1 1 0 2 -1 0 0 0 0
Net Change 0 0 1 0 0 0 -1 0 0 0
Cash & Cash Eqvt 0 0 1 1 2 1 0 1 0 0

KMS Medisurgi Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 74.42 74.42 74.42 74.42 74.42 74.42 74.42 74.42 72.73
Public 25.58 25.58 25.58 25.58 25.58 25.58 25.58 25.58 27.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

KMS Medisurgi Ltd. Announcements

Mon, 08 Apr 2024
Certificate From PCS Under Regulation 40(10)
Certificate PCS under Regulation 40(10)
Mon, 08 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for quarter ended March 31 2024
Mon, 08 Apr 2024
Compliance Certificate For Period Ended March 31 2024
Compliance certificate for period ended March 31 2024

KMS Medisurgi Ltd. Technical Scans

No Scans Found

KMS Medisurgi Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,520.15 +2.3%
Cipla Ltd. 113,471.29 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,218.75 +4.5%
Divi's Laboratories Ltd. 101,959.84 3,843.80 +0.8%
Zydus Lifesciences Ltd. 95,944.41 951.25 +1.9%
Mankind Pharma Ltd. 95,926.91 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,384.10 +1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.60 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,384.10 +1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.38 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,384.10 +1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,384.10 +1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,384.10 +1.6%

KMS Medisurgi Ltd. FAQ's

What is KMS Medisurgi share price?

Can I buy KMS Medisurgi shares now?

What is the Dividend Yield of KMS Medisurgi?

What is the Market Cap of KMS Medisurgi?

What are the key metrics to analyse KMS Medisurgi?

What is the 52 Week High and Low of KMS Medisurgi?